Aromiel Respiratoire
Food supplement declared in France, declaration No 2021-7-1153, decision dated 22 July 2021
Aromiel Respiratoire (Abiessence) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- Abiessence
- Food business operator placing the product on the market
- SARL ABIESSENCE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Autre : Liquide visqueux
- Daily dose
- 7 gr
- Directions for use
- Prendre 1 cuillière à café par jour chaque matin à jeun pendant 2 semaines
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Hypertension, Nourrissons (moins de 1 an), Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Voies respiratoires
Declaration 177582, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Abies alba Mill. | Essence (parties aériennes) | Distillation | 0.01218 g |
| Citrus limon (L.) Burm. f. | Zeste | Distillation | 0.00203 g |
| Eucalyptus radiata A.Cunn. ex DC. | Essence (feuille) | Distillation | 0.00203 g |
| Thymus vulgaris L. | Essence (sommités fleuries) | Distillation | 0.00203 g |
| Mentha spicata L. | Essence (sommités fleuries) | Distillation | 0.001127 g |
| Mentha x piperita L. | Essence (parties aériennes) | Distillation | 0.000903 g |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux femmes enceintes et allaitantes et aux enfants de moins de 6 ans Demandez conseil à un professionnel de santé en cas d'insuffisance rénale sévère. Pas d'utilisation prolongée. Déconseillé chez les enfants de moins de 12 ans en cas d'antécédents d'épilepsie ou de convulsions Ne pas utiliser avant exposition au soleil. Surveillez la pression artérielle chez les personnes hypertendues Pas d'utilisation prolongée Déconseillé en cas d'antécédents d'épilepsie ou de convulsions Demandez conseil à un professionnel de santé en cas d’obstruction des voies biliaires Déconseillé chez les moins de 12 ans en cas d'antécédent de convulsion. Demandez conseil à un professionnel de santé en cas de traitement antiépileptique ou d'antécédent de convulsion. Ne pas dépasser deux semaines de prise
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thymus vulgaris L.
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Mentha x piperita L.
Read the warning, when it applies and the studies cited
PEPPERMINT - MENTHA X PIPERITA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Abiessence
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.